Literature DB >> 16932856

Epilepsy in autism spectrum disorders.

Roberto Canitano1.   

Abstract

Epilepsy is quite common in autism spectrum disorders, and it is increasingly recognized as an additional clinical problem that must be dealt with. The rate of comorbidity varies, depending upon the age and type of disorder, and currently the conservative estimate of comorbidity cases is 20-25% of the whole spectrum. Major risk factors for seizure occurrence are mental retardation and additional neurological disorders, as well as some specific associated medical conditions. Autism with regression has been reported in one-third of children with previously normal or nearly normal development. In an unknown proportion of these subjects, epileptic disorders are concomitant, leading to so-called autistic epileptiform regression. Furthermore, epileptiform abnormalities without seizures are frequent in this population and their role in the development of the nuclear disturbances of autism is controversial. The therapeutic approaches to epilepsy in autism are conventional treatments, yet when seizures are not evident, there is still controversy. Anticonvulsant medications could also potentially interfere with mood and behavioral disturbances frequently observed in ASD. The current understanding of the association between epilepsy and autism is still limited, but from a clinical point of view this association should not be overlooked, and it should be routinely investigated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16932856     DOI: 10.1007/s00787-006-0563-2

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  58 in total

1.  Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders.

Authors:  B G Neville
Journal:  Pediatrics       Date:  1999-09       Impact factor: 7.124

Review 2.  Electroencephalography findings in autism: similarities and differences from Landau-Kleffner syndrome.

Authors:  Paul M Levisohn
Journal:  Semin Pediatr Neurol       Date:  2004-09       Impact factor: 1.636

3.  Autistic regression with rolandic spikes.

Authors:  R Nass; O Devinsky
Journal:  Neuropsychiatry Neuropsychol Behav Neurol       Date:  1999-07

4.  An open trial of divalproex sodium in autism spectrum disorders.

Authors:  E Hollander; R Dolgoff-Kaspar; C Cartwright; R Rawitt; S Novotny
Journal:  J Clin Psychiatry       Date:  2001-07       Impact factor: 4.384

Review 5.  Seizures and epilepsy among children with language regression and autistic spectrum disorders.

Authors:  Edwin Trevathan
Journal:  J Child Neurol       Date:  2004-08       Impact factor: 1.987

6.  Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex.

Authors:  Patrick F Bolton; Rebecca J Park; J Nicholas P Higgins; Paul D Griffiths; Andrew Pickles
Journal:  Brain       Date:  2002-06       Impact factor: 13.501

7.  Seizure disorders in autism.

Authors:  F R Volkmar; D S Nelson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1990-01       Impact factor: 8.829

Review 8.  Acquired epileptiform aphasia in children (Landau-Kleffner syndrome).

Authors:  T W Deonna
Journal:  J Clin Neurophysiol       Date:  1991-07       Impact factor: 2.177

Review 9.  AEDs and psychotropic drugs in children with autism and epilepsy.

Authors:  Roberto Tuchman
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2004

Review 10.  Epidemiological surveys of autism and other pervasive developmental disorders: an update.

Authors:  Eric Fombonne
Journal:  J Autism Dev Disord       Date:  2003-08
View more
  72 in total

1.  Early-life seizures result in deficits in social behavior and learning.

Authors:  Joaquin N Lugo; John W Swann; Anne E Anderson
Journal:  Exp Neurol       Date:  2014-03-29       Impact factor: 5.330

2.  Autism and Epilepsy: Exploring the Relationship Using Experimental Models.

Authors:  Carl E Stafstrom; Tim A Benke
Journal:  Epilepsy Curr       Date:  2015 Jul-Aug       Impact factor: 7.500

3.  Sodium phenylbutyrate reduces repetitive self-grooming behavior and rescues social and cognitive deficits in mouse models of autism.

Authors:  Young-Kyoung Ryu; Hye-Yeon Park; Jun Go; Dong-Hee Choi; Young-Keun Choi; Myungchull Rhee; Chul-Ho Lee; Kyoung-Shim Kim
Journal:  Psychopharmacology (Berl)       Date:  2021-03-16       Impact factor: 4.530

Review 4.  Sensory perception in autism.

Authors:  Caroline E Robertson; Simon Baron-Cohen
Journal:  Nat Rev Neurosci       Date:  2017-09-29       Impact factor: 34.870

Review 5.  Is birth a critical period in the pathogenesis of autism spectrum disorders?

Authors:  Yehezkel Ben-Ari
Journal:  Nat Rev Neurosci       Date:  2015-07-08       Impact factor: 34.870

6.  The role of GABAergic system in neurodevelopmental disorders: a focus on autism and epilepsy.

Authors:  Paola Sgadò; Mark Dunleavy; Sacha Genovesi; Giovanni Provenzano; Yuri Bozzi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-09-09

7.  Autism-linked CHD gene expression patterns during development predict multi-organ disease phenotypes.

Authors:  Sahrunizam Kasah; Christopher Oddy; M Albert Basson
Journal:  J Anat       Date:  2018-10-02       Impact factor: 2.610

8.  Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice.

Authors:  Jing Zhou; Jacqueline Blundell; Shiori Ogawa; Chang-Hyuk Kwon; Wei Zhang; Christopher Sinton; Craig M Powell; Luis F Parada
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

9.  Systematic genotype-phenotype analysis of autism susceptibility loci implicates additional symptoms to co-occur with autism.

Authors:  Jacobine E Buizer-Voskamp; Lude Franke; Wouter G Staal; Emma van Daalen; Chantal Kemner; Roel A Ophoff; Jacob As Vorstman; Herman van Engeland; Cisca Wijmenga
Journal:  Eur J Hum Genet       Date:  2009-11-25       Impact factor: 4.246

10.  Recent advances in the pathogenesis of syndromic autisms.

Authors:  A Benvenuto; B Manzi; R Alessandrelli; C Galasso; P Curatolo
Journal:  Int J Pediatr       Date:  2009-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.